Taken together, the present results suggest that IL-27 exerts anti-proliferative activity against human melanomas by mechanisms similar to those of IFN-α in a STAT1/IRF-1–dependent manner and partly in a TRAIL-dependent manner. Here, IRF1 is linked to melanoma.